查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1513618

藥物濫用檢測服務市場:全球產業分析，規模，佔有率，成長，趨勢，預測，2024年～2033年

Drug of Abuse Testing Services Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於全球藥物濫用檢測服務市場的綜合報告。該報告全面評估了主要市場動態，包括驅動因素、趨勢、機會和挑戰，並提供了有關市場結構的詳細見解。

關鍵見解

  • 藥物濫用檢測服務的市場規模（2024 年）：32 億美元
  • 預計市值（2033 年）：51 億美元
  • 全球市場成長率（2023-2033 年複合年增長率）：5.4%：5.4%

藥物濫用檢測服務市場 - 研究範圍：

藥物濫用檢測服務在識別和管理藥物濫用問題、確保工作場所安全以及支持法律和醫療目標方面發揮著重要作用。這些服務包括各種測試方法，包括尿液測試、頭髮測試、唾液測試和血液測試，以檢測是否有非法和受管制物質。該市場為醫院、診斷實驗室、執法機構和工作場所篩檢計畫提供服務，提供各種檢測解決方案和技術。

推動市場成長的因素：

全球藥物濫用檢測服務市場由藥物濫用盛行、嚴格的政府法規以及工作場所藥物檢測需求不斷增長等幾個關鍵因素推動。人們越來越認識到藥物濫用對健康和生產力的負面影響，這推動了對有效檢測解決方案的需求。快速準確檢測方法的開發等技術進步正在提高藥物檢測服務的效率和可靠性，進一步推動市場成長。此外，新興國家檢測服務的擴展和數位健康平台的整合正在為市場參與者創造新的機會。

市場限制因素：

儘管成長前景廣闊，但藥物濫用檢測服務市場仍面臨隱私問題、監管合規性和先進檢測技術的高成本等挑戰。有關藥物測試性能和報告的嚴格規定給服務提供者帶來了合規負擔，影響了市場進入障礙和營運成本。此外，藥物檢測結果可能出現假陽性和假陰性，這對檢測服務的可靠性和可接受性構成了挑戰。解決這些監管和技術障礙需要持續投資研發、與監管機構合作以及實施強有力的品質控制措施。

市場機會：

由於技術創新、不斷發展的醫療保健政策以及擴大採用遠距醫療服務，藥物濫用檢測服務市場提供了巨大的成長機會。人工智慧、機器學習等先進技術的融合，提高了藥物檢測過程的準確性和效率。擴大藥物檢測服務在疼痛管理、心理健康治療和運動興奮劑控制方面的應用，擴大市場範圍並刺激創新。策略合作夥伴關係、研發投資以及引入具有成本效益的檢測解決方案對於利用新機會並保持在動態濫用藥物檢測市場中的領導地位至關重要。

本報告解決的關鍵問題

  • 推動藥物濫用檢測服務市場全球成長的關鍵因素有哪些？
  • 哪些測試方法和應用程式正在推動不同產業採用藥物測試服務？
  • 技術進步如何改變藥物濫用檢測服務市場的競爭格局？
  • 誰是藥物濫用檢測服務市場的主要參與者？ 他們採取哪些策略來維持市場地位？
  • 全球藥物濫用檢測服務市場的新趨勢和未來前景是什麼？

目錄

第1章 摘要整理

第2章 市場概要

  • 市場範圍/分類
  • 市場定義/範圍/限制

第3章 市場背景

  • 市場動態
  • 情勢預測
  • 機會地圖分析
  • 產品生命週期分析
  • 投資可行性矩陣
  • PESTLE和波特五力分析
  • 法規情形
  • 各地區的親市場預測

第4章 全球藥物濫用檢測服務市場分析

  • 過去的市場規模金額(10億美元)分析，2019年～2023年
  • 現在及未來市場規模金額(10億美元)預測，2024年～2033年
    • 前一年同期比較成長趨勢分析
    • 絕對額的機會分析

第五章藥物濫用檢測服務的全球市場分析：藥物類型

  • 簡介/主要發現
  • 2019-2023 年藥物類型劃分的過去市場規模與價值（十億美元）分析
  • 2024-2033 年藥物類型劃分的當前和未來市場規模價值（十億美元）分析和預測
    • 酒精
    • 大麻/大麻
    • 可卡因
    • 阿片類藥物
    • 安非他明/甲基安非他明
    • LSD
    • 其他藥物類型
  • 年成長趨勢分析：依藥物類型劃分，2019-2023 年
  • 絕對價值機會分析：依藥物類型，2024-2033 年

第6章 全球藥物濫用檢測服務市場分析:各地區

  • 簡介
  • 過去的市場規模金額(10億美元)的分析:各地區，2019年～2023年
  • 目前市場規模金額(10億美元)的分析與預測:各地區，2024年～2033年
    • 北美
    • 南美
    • 歐洲
    • 亞太地區
    • 中東·非洲
  • 市場魅力分析:各地區

第7章 北美的藥物濫用檢測服務市場分析(各國)

第8章 南美的藥物濫用檢測服務市場分析(各國)

第9章 歐洲的藥物濫用檢測服務市場分析(各國)

第10章 亞太地區的藥物濫用檢測服務市場分析(各國)

第11章 中東·非洲的藥物濫用檢測服務市場分析(各國)

第12章 主要國家的藥物濫用檢測服務市場分析

  • 美國
  • 加拿大
  • 巴西
  • 墨西哥
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 俄羅斯
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列

第13章 市場結構分析

  • 競爭儀表板
  • 競爭基準
  • 主要企業的市場佔有率分析

第14章 競爭分析

  • 競爭的詳細資訊
    • Quest Diagnostics, Inc.
    • Abbott Laboratories
    • Clinical Reference Laboratory, Inc.
    • Laboratory Corporation of America Holdings
    • Cordant Health Solutions
    • Legacy Medical Services, LLC.
    • DrugScan
    • Omega Laboratories, Inc.
    • Psychemedics Corporation
    • Mayo Clinic Laboratories

第15章 所使用的前提條件與縮寫

第16章 調查手法

簡介目錄
Product Code: PMRREP33256

Persistence Market Research has recently released a comprehensive report on the worldwide market for drug of abuse testing services. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Drug of Abuse Testing Services Market Size (2024E): USD 3.2 Billion
  • Projected Market Value (2033F): USD 5.1 Billion
  • Global Market Growth Rate (CAGR 2023 to 2033): 5.4%

Drug of Abuse Testing Services Market - Report Scope:

Drug of abuse testing services play a crucial role in identifying and managing substance abuse issues, ensuring workplace safety, and supporting legal and medical purposes. These services encompass various testing methods, including urine, hair, saliva, and blood tests, to detect the presence of illicit drugs and controlled substances. The market caters to hospitals, diagnostic laboratories, law enforcement agencies, and workplace screening programs, offering a range of testing solutions and technologies.

Market Growth Drivers:

The global drug of abuse testing services market is propelled by several key factors, including the increasing prevalence of substance abuse, stringent government regulations, and the rising demand for workplace drug testing. The growing awareness about the adverse effects of drug abuse on health and productivity drives the need for effective testing solutions. Technological advancements, such as the development of rapid and accurate testing methods, enhance the efficiency and reliability of drug testing services, further fueling market growth. Moreover, the expansion of testing services in emerging economies and the integration of digital health platforms create new opportunities for market players.

Market Restraints:

Despite promising growth prospects, the drug of abuse testing services market faces challenges related to privacy concerns, regulatory compliance, and the high cost of advanced testing technologies. Stringent regulations governing the conduct and reporting of drug tests impose compliance burdens on service providers, affecting market entry barriers and operational costs. Additionally, the potential for false positives and negatives in drug testing results poses challenges for the credibility and acceptance of testing services. Addressing these regulatory and technical barriers requires continuous investment in research and development, collaboration with regulatory bodies, and the implementation of robust quality control measures.

Market Opportunities:

The drug of abuse testing services market presents significant growth opportunities driven by technological innovations, evolving healthcare policies, and the increasing adoption of telehealth services. The integration of advanced technologies, such as artificial intelligence and machine learning, improves the accuracy and efficiency of drug testing processes. The expanding application of drug testing services in pain management, mental health treatment, and sports doping control broadens the market scope and stimulates innovation. Strategic partnerships, investment in research and development, and the introduction of cost-effective testing solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic drug of abuse testing landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the drug of abuse testing services market globally?
  • Which testing methods and applications are driving the adoption of drug testing services across different sectors?
  • How are technological advancements reshaping the competitive landscape of the drug of abuse testing services market?
  • Who are the key players contributing to the drug of abuse testing services market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global drug of abuse testing services market?

Competitive Intelligence and Business Strategy:

Leading players in the global drug of abuse testing services market, including Abbott Laboratories, Quest Diagnostics, and LabCorp, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced testing solutions, including rapid test kits, automated analyzers, and digital platforms, catering to diverse client needs and regulatory requirements. Collaborations with healthcare providers, employers, and law enforcement agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and client education fosters market growth and enhances service reliability in the rapidly evolving drug of abuse testing landscape.

Key Companies Profiled:

  • Quest Diagnostics
  • Abbott Laboratories
  • Cordant Health Solutions
  • Omega Laboratories
  • Mayo Clinic Laboratories
  • Air Methods
  • ALPHASTAR
  • Clinical Reference Laboratory, Inc.
  • Laboratory Corporation of America Holdings
  • Cordant Health Solutions
  • Legacy Medical Services, LLC
  • DrugScan
  • Psychemedics Corporation

Market Segments Covered in Drug of Abuse Testing Services Market Analysis

By Drug Type

  • Alcohol
  • Cannabis/Marijuana
  • Cocaine
  • Opioids
  • Amphetamine & Methamphetamine
  • LSD

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Product Life Cycle Analysis
  • 3.5. Investment Feasibility Matrix
  • 3.6. PESTLE and Porter's Analysis
  • 3.7. Regulatory Landscape
    • 3.7.1. By Key Regions
    • 3.7.2. By Key Countries
  • 3.8. Regional Parent Market Outlook

4. Global Drug of Abuse Testing Services Market Analysis 2019-2023 and Forecast, 2024-2033

  • 4.1. Historical Market Size Value (US$ Bn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Bn) Projections, 2024-2033
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Drug of Abuse Testing Services Market Analysis 2019-2023 and Forecast 2024-2033, By Drug Type

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Bn) Analysis By Drug Type, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Drug Type, 2024-2033
    • 5.3.1. Alcohol
    • 5.3.2. Cannabis/Marijuana
    • 5.3.3. Cocaine
    • 5.3.4. Opioids
    • 5.3.5. Amphetamine & Methamphetamine
    • 5.3.6. LSD
    • 5.3.7. Other Drug Types
  • 5.4. Y-o-Y Growth Trend Analysis By Drug Type, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Drug Type, 2024-2033

6. Global Drug of Abuse Testing Services Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 6.1. Introduction
  • 6.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2019-2023
  • 6.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2024-2033
    • 6.3.1. North America
    • 6.3.2. Latin America
    • 6.3.3. Europe
    • 6.3.4. Asia Pacific
    • 6.3.5. Middle East and Africa
  • 6.4. Market Attractiveness Analysis By Region

7. North America Drug of Abuse Testing Services Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 7.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 7.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 7.2.1. By Country
      • 7.2.1.1. U.S.
      • 7.2.1.2. Canada
    • 7.2.2. By Drug Type
  • 7.3. Market Attractiveness Analysis
    • 7.3.1. By Country
    • 7.3.2. By Drug Type
  • 7.4. Key Takeaways

8. Latin America Drug of Abuse Testing Services Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 8.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 8.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 8.2.1. By Country
      • 8.2.1.1. Brazil
      • 8.2.1.2. Mexico
      • 8.2.1.3. Rest of Latin America
    • 8.2.2. By Drug Type
  • 8.3. Market Attractiveness Analysis
    • 8.3.1. By Country
    • 8.3.2. By Drug Type
  • 8.4. Key Takeaways

9. Europe Drug of Abuse Testing Services Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 9.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 9.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 9.2.1. By Country
      • 9.2.1.1. Germany
      • 9.2.1.2. U.K.
      • 9.2.1.3. France
      • 9.2.1.4. Spain
      • 9.2.1.5. Italy
      • 9.2.1.6. Russia
      • 9.2.1.7. Rest of Europe
    • 9.2.2. By Drug Type
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Drug Type
  • 9.4. Key Takeaways

10. Asia Pacific Drug of Abuse Testing Services Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 10.2.1. By Country
      • 10.2.1.1. China
      • 10.2.1.2. Japan
      • 10.2.1.3. India
      • 10.2.1.4. South Korea
      • 10.2.1.5. Australia
      • 10.2.1.6. Rest of APAC
    • 10.2.2. By Drug Type
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Drug Type
  • 10.4. Key Takeaways

11. Middle East and Africa Drug of Abuse Testing Services Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 11.2.1. By Country
      • 11.2.1.1. South Africa
      • 11.2.1.2. Saudi Arabia
      • 11.2.1.3. UAE
      • 11.2.1.4. Israel
      • 11.2.1.5. Rest of MEA
    • 11.2.2. By Drug Type
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Drug Type
  • 11.4. Key Takeaways

12. Key Countries Drug of Abuse Testing Services Market Analysis

  • 12.1. U.S.
    • 12.1.1. Pricing Analysis
    • 12.1.2. Market Share Analysis, 2024
      • 12.1.2.1. By Drug Type
  • 12.2. Canada
    • 12.2.1. Pricing Analysis
    • 12.2.2. Market Share Analysis, 2024
      • 12.2.2.1. By Drug Type
  • 12.3. Brazil
    • 12.3.1. Pricing Analysis
    • 12.3.2. Market Share Analysis, 2024
      • 12.3.2.1. By Drug Type
  • 12.4. Mexico
    • 12.4.1. Pricing Analysis
    • 12.4.2. Market Share Analysis, 2024
      • 12.4.2.1. By Drug Type
  • 12.5. Germany
    • 12.5.1. Pricing Analysis
    • 12.5.2. Market Share Analysis, 2024
      • 12.5.2.1. By Drug Type
  • 12.6. U.K.
    • 12.6.1. Pricing Analysis
    • 12.6.2. Market Share Analysis, 2024
      • 12.6.2.1. By Drug Type
  • 12.7. France
    • 12.7.1. Pricing Analysis
    • 12.7.2. Market Share Analysis, 2024
      • 12.7.2.1. By Drug Type
  • 12.8. Spain
    • 12.8.1. Pricing Analysis
    • 12.8.2. Market Share Analysis, 2024
      • 12.8.2.1. By Drug Type
  • 12.9. Italy
    • 12.9.1. Pricing Analysis
    • 12.9.2. Market Share Analysis, 2024
      • 12.9.2.1. By Drug Type
  • 12.10. Russia
    • 12.10.1. Pricing Analysis
    • 12.10.2. Market Share Analysis, 2024
      • 12.10.2.1. By Drug Type
  • 12.11. China
    • 12.11.1. Pricing Analysis
    • 12.11.2. Market Share Analysis, 2024
      • 12.11.2.1. By Drug Type
  • 12.12. Japan
    • 12.12.1. Pricing Analysis
    • 12.12.2. Market Share Analysis, 2024
      • 12.12.2.1. By Drug Type
  • 12.13. India
    • 12.13.1. Pricing Analysis
    • 12.13.2. Market Share Analysis, 2024
      • 12.13.2.1. By Drug Type
  • 12.14. South Korea
    • 12.14.1. Pricing Analysis
    • 12.14.2. Market Share Analysis, 2024
      • 12.14.2.1. By Drug Type
  • 12.15. Australia
    • 12.15.1. Pricing Analysis
    • 12.15.2. Market Share Analysis, 2024
      • 12.15.2.1. By Drug Type
  • 12.16. South Africa
    • 12.16.1. Pricing Analysis
    • 12.16.2. Market Share Analysis, 2024
      • 12.16.2.1. By Drug Type
  • 12.17. Saudi Arabia
    • 12.17.1. Pricing Analysis
    • 12.17.2. Market Share Analysis, 2024
      • 12.17.2.1. By Drug Type
  • 12.18. UAE
    • 12.18.1. Pricing Analysis
    • 12.18.2. Market Share Analysis, 2024
      • 12.18.2.1. By Drug Type
  • 12.19. Israel
    • 12.19.1. Pricing Analysis
    • 12.19.2. Market Share Analysis, 2024
      • 12.19.2.1. By Drug Type

13. Market Structure Analysis

  • 13.1. Competition Dashboard
  • 13.2. Competition Benchmarking
  • 13.3. Market Share Analysis of Top Players
    • 13.3.1. By Regional
    • 13.3.2. By Drug Type

14. Competition Analysis

  • 14.1. Competition Deep Dive
    • 14.1.1. Quest Diagnostics, Inc.
      • 14.1.1.1. Overview
      • 14.1.1.2. Product Portfolio
      • 14.1.1.3. Profitability by Market Segments
      • 14.1.1.4. Sales Footprint
      • 14.1.1.5. Strategy Overview
        • 14.1.1.5.1. Marketing Strategy
    • 14.1.2. Abbott Laboratories
      • 14.1.2.1. Overview
      • 14.1.2.2. Product Portfolio
      • 14.1.2.3. Profitability by Market Segments
      • 14.1.2.4. Sales Footprint
      • 14.1.2.5. Strategy Overview
        • 14.1.2.5.1. Marketing Strategy
    • 14.1.3. Clinical Reference Laboratory, Inc.
      • 14.1.3.1. Overview
      • 14.1.3.2. Product Portfolio
      • 14.1.3.3. Profitability by Market Segments
      • 14.1.3.4. Sales Footprint
      • 14.1.3.5. Strategy Overview
        • 14.1.3.5.1. Marketing Strategy
    • 14.1.4. Laboratory Corporation of America Holdings
      • 14.1.4.1. Overview
      • 14.1.4.2. Product Portfolio
      • 14.1.4.3. Profitability by Market Segments
      • 14.1.4.4. Sales Footprint
      • 14.1.4.5. Strategy Overview
        • 14.1.4.5.1. Marketing Strategy
    • 14.1.5. Cordant Health Solutions
      • 14.1.5.1. Overview
      • 14.1.5.2. Product Portfolio
      • 14.1.5.3. Profitability by Market Segments
      • 14.1.5.4. Sales Footprint
      • 14.1.5.5. Strategy Overview
        • 14.1.5.5.1. Marketing Strategy
    • 14.1.6. Legacy Medical Services, LLC.
      • 14.1.6.1. Overview
      • 14.1.6.2. Product Portfolio
      • 14.1.6.3. Profitability by Market Segments
      • 14.1.6.4. Sales Footprint
      • 14.1.6.5. Strategy Overview
        • 14.1.6.5.1. Marketing Strategy
    • 14.1.7. DrugScan
      • 14.1.7.1. Overview
      • 14.1.7.2. Product Portfolio
      • 14.1.7.3. Profitability by Market Segments
      • 14.1.7.4. Sales Footprint
      • 14.1.7.5. Strategy Overview
        • 14.1.7.5.1. Marketing Strategy
    • 14.1.8. Omega Laboratories, Inc.
      • 14.1.8.1. Overview
      • 14.1.8.2. Product Portfolio
      • 14.1.8.3. Profitability by Market Segments
      • 14.1.8.4. Sales Footprint
      • 14.1.8.5. Strategy Overview
        • 14.1.8.5.1. Marketing Strategy
    • 14.1.9. Psychemedics Corporation
      • 14.1.9.1. Overview
      • 14.1.9.2. Product Portfolio
      • 14.1.9.3. Profitability by Market Segments
      • 14.1.9.4. Sales Footprint
      • 14.1.9.5. Strategy Overview
        • 14.1.9.5.1. Marketing Strategy
    • 14.1.10. Mayo Clinic Laboratories
      • 14.1.10.1. Overview
      • 14.1.10.2. Product Portfolio
      • 14.1.10.3. Profitability by Market Segments
      • 14.1.10.4. Sales Footprint
      • 14.1.10.5. Strategy Overview
        • 14.1.10.5.1. Marketing Strategy

15. Assumptions & Acronyms Used

16. Research Methodology